Imidazo[1,2-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)(185796-58-1)
- Name: Imidazo[1,2-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)
- Synonyms:Imidazo[1,2-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)
- Molecular Formula:C7H11 N3
- Molecular Weight:137.18234
- CAS Registry Number:185796-58-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.185796-58-1 Imidazo[1,2-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.185796-58-1 Imidazo[1,2-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)
Assay:NLT 98% Appearance:White powder Package:Aluminum bag/Carton Drum Storage:Store in a tightly closed container, in a cool and dry place. Transportation:By air Application:Used in producing API
Min. Order:0
Supplier:Hangzhou Huarong Pharm Co., Ltd. [
China (Mainland)] CAS No.185796-58-1 Imidazo[1,2-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Imidazo[1,2-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.185796-58-1 5H,6H,7H,8H-imidazo[1,2-a]pyridin-6-amine;185796-58-1
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 185839-73-0/1H-1,2,3-Triazolo[4,5-c]pyridine,1-hydroxy-(9CI)
- 185839-72-9/3H-1,2,3-Triazolo[4,5-c]pyridine,3-hydroxy-(9CI)
- 185836-34-4/(R)-(+)-4-(METHOXYMETHYL)-1,3-DIOXOLAN-2-ONE
- 185835-97-6/(5S)-5-(METHOXYMETHYL)-3-[6-(4,4,4-TRIFLUOROBUTOXY)-1,2-BENZOXAZOL-3-YL]-1,3-OXAZOLIDIN-2-ONE
- 185815-61-6/(R)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID
- 185812-86-6/PALLADIUM (I) TRI-TERT-BUTYLPHOSPHINE BROMIDE
- 185807-29-8/(4S)-4,8-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 185798-86-1/(1H-IMIDAZOL-4-YL)(PYRIDIN-4-YL)METHANOL
- 185797-58-4/Imidazo[1,2-a]pyridin-7(1H)-one, 5,6-dihydro- (9CI)
- 185797-45-9/5H-Pyrrolo[1,2-a]imidazole-7-methanamine,6,7-dihydro-(9CI)
- 185796-64-9/5H-Pyrrolo[1,2-a]imidazol-7-amine,6,7-dihydro-(9CI)
- 185796-62-7/Imidazo[1,5-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)
- 185796-58-1/Imidazo[1,2-a]pyridin-6-amine, 5,6,7,8-tetrahydro- (9CI)
- 185760-08-1/2,5-Pyrrolidinedione,1-ethyl-3-(1-methylethyl)-(9CI)
- 185757-19-1/Pyrrolo[1,2-a]pyrazine-1,3,6(2H,4H,7H)-trione, dihydro- (9CI)
- 185757-17-9/Pyrrolo[1,2-a][1,4]diazocine-1,6-dione, octahydro- (9CI)
- 185757-16-8/1H-Pyrrolo[1,2-a][1,4]diazepine-1,5(2H)-dione,hexahydro-(9CI)
- 185747-98-2/Imidazo[5,1-b]thiazole-7-carboxaldehyde (9CI)
- 185746-06-9/3H-Pyrazol-3-one, 4-(chloroacetyl)-2,4-dihydro-2,5-dimethyl- (9CI)
- 185743-65-1/4(1H)-Pyridinone, 3-hydroxy-1-[2-(2-hydroxyethoxy)ethyl]-2-methyl- (9CI)
- 185740-18-5/CETYLOXYPROPYL GLYCERYL METHOXYPROPYL MYRISTAMIDE
- 185702-18-5/ACRYSOL 44
- 185701-95-5/α-Hydro-ω-[3-(dimethoxymethylsilyl)propoxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol(4:1)
- 185693-00-9/PYRROLIDIN-2-YL-CARBAMIC ACID TERT-BUTYL ESTER
- 185692-51-7/2-Benzyl-hexahydro-cyclopenta[c]pyrrol-4-one
- 185689-55-8/Benzoic acid, 6-amino-3-(dimethylamino)-2-methyl- (9CI)
- 185689-54-7/Benzoic acid, 2-amino-3-(aminomethyl)-6-methyl-, methyl ester (9CI)
- 185689-48-9/Benzoic acid, 6-amino-3-(aminomethyl)-2-methyl-, methyl ester (9CI)
- 185696-11-1/Hydrazinecarboxylic acid, 2-methyl-1-phenyl-, methyl ester
- 185698-23-1/MCA-PRO-LEU-GLY-PRO-D-LYS(DNP)-OH